|
Johnson, Daniel H; Gebretsadik, Tebeb; Shintani, Ayumi et al. (2013) Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose. Br J Clin Pharmacol 75:997-1006
|
|
Kohli, Utkarsh; Pandharipande, Pratik; Muszkat, Mordechai et al. (2012) CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol 68:937-42
|
|
Kohli, Utkarsh; Hahn, Maureen K; English, Brett A et al. (2011) Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenet Genomics 21:171-8
|
|
Ho, Richard H; Leake, Brenda F; Kilkenny, Dawn M et al. (2010) Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics 20:45-57
|
|
Kohli, Utkarsh; Muszkat, Mordechai; Sofowora, Gbenga G et al. (2010) Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain 14:154-9
|
|
Muszkat, Mordechai; Kurnik, Daniel; Sofowora, Gbenga G et al. (2010) Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. J Hypertens 28:278-84
|
|
Muszkat, Mordechai; Bialer, Omer; Blotnick, Simcha et al. (2010) Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. Clin Ther 32:347-56
|
|
Li, Chun; Schwarz, Ute I; Ritchie, Marylyn D et al. (2009) Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood 113:3925-30
|
|
Haas, David W; Gebretsadik, Tebeb; Mayo, Gail et al. (2009) Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. J Infect Dis 199:872-80
|
|
Kurnik, Daniel; Sofowora, Gbenga G; Donahue, John P et al. (2008) Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein. Anesthesiology 109:1092-9
|
Showing the most recent 10 out of 351 publications
